Heyou International Hospital

Heyou International Hospital Group originates from the public welfare aspiration of Mr. He Xiangjian, founder of Midea, to "benefit the hometown and give back to society." The group's headquarters is located at No. 1, Heping Road, Beijiao Town, Shunde District, Foshan City, Guangdong Province, situated in the core area of the Guangdong-Hong Kong-Macao Greater Bay Area and the geometric center of the Guangzhou-Foshan极点. It is a comprehensive medical industry group benchmarking international high-quality medical services. Currently, Heyou International Hospital Group includes one non-profit tertiary general hospital (Heyou Hospital), one Sino-Hong Kong joint venture secondary general hospital (Heyou Zhizhen Hospital), one primary general hospital (Meihe Hospital), and one medical aesthetics institution (Feisi Medical Aesthetics). Heyou Hospital and Heyou Zhizhen Hospital officially opened on June 28, 2024, as key construction projects of Guangdong Province, with a total construction area of 580,000 square meters, planning 1,500 beds, and a green rate as high as 30%. They include functional areas such as outpatient services, inpatient care, administrative offices, international medical services, proton and heavy ion tumor treatment, academic exchange, medical research, and education and training, along with dedicated talent housing for medical staff. Among them, Heyou Hospital is a non-profit tertiary general hospital with medical service prices on par with public tertiary hospitals, providing patients with high-quality and affordable medical services to reduce the burden of medical expenses. The hospital has obtained designated medical insurance service qualifications for outpatient services, inpatient care, maternity insurance, and work-related injury insurance, allowing citizens to enjoy medical insurance reimbursement. All future revenue surplus will be used for hospital development, medical research, and social welfare. Heyou Zhizhen Hospital complements the affordable medical services of Heyou Hospital, taking world-leading hospitals as models and committing to providing diverse, multi-level medical services to meet the personalized needs of every patient. The proton and heavy ion center under construction by Heyou is a clinical and research institution equipped with both proton and heavy ion radiation therapy technologies, featuring a combined proton-heavy ion machine. Equipment commissioning is expected to be completed in 2026, with clinical trials starting in 2027, to enhance precision oncology treatment. As an incubator and testing ground for Heyou, Meihe Hospital successfully fulfilled its strategic mission in the early stage and now serves as a "hospital at the doorstep" for surrounding community residents, offering customized health check-ups and other distinctive medical and health services. Feisi Medical Aesthetics is a medical aesthetics institution integrating skin aesthetics, minimally invasive aesthetics, aesthetic surgery, and lifestyle aesthetics, advocating the concept of "medical first, aesthetics second" to provide personalized beauty solutions for beauty seekers. Heyou International Hospital Group closely follows the national strategy of "Healthy China 2030," actively responds to policy calls for building a multi-level medical service system, deeply participates in and embraces the new landscape of healthcare system reform, and is committed to building a large medical group with Heyou Hospital as the core, Heyou Zhizhen Hospital working in coordination, and other associated business units providing joint support. It is dedicated to constructing a closed loop of full-lifecycle health services, creating a matrix medical resource platform, providing comprehensive, high-quality, and efficient medical services to patients, and making greater contributions to building a healthy China and achieving universal health.